FDA Inspection 1149124 — Thomas G. Martin III, MD
The FDA completed an inspection of Thomas G. Martin III, MD on July 29, 2021 in San Francisco, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 29, 2021
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- San Francisco, CA (United States)